We next generated a dormancy gene signature from our findings that included the expression levels of SLURP1, INFGR2, KLF4, and CD200 in cancer cells along with CD200R1 in NK cells and tested for links to immunotherapy responses. The gene discussed is CD200R1; the disease is cancer.